1. Autophagy Apoptosis
  2. Autophagy Apoptosis
  3. PFK-158

PFK-158 is a potent and selective PFKFB3 inhibitor with an IC50 value 137 nM. PFK-158 reduces glucose uptake, ATP production, lactate release, and induces apoptosis and autophagy in cancer cells. PFK-158 has broad anti-tumor activity. PFK-158 can also enhance Colistin's resistance to bacteria.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

CAS No. : 1462249-75-7

사이즈 가격 재고 수량
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
해외재고보유
Solution
10 mM * 1 mL in DMSO 해외재고보유
Solid
1 mg 해외재고보유
5 mg 해외재고보유
10 mg 해외재고보유
50 mg 해외재고보유
100 mg 해외재고보유
200 mg   견적 받기  
500 mg   견적 받기  

* 장바구니에 담기 전 물품의 수량을 선택해 주십시오.

This product is a controlled substance and not for sale in your territory.

고객리뷰

Based on 11 publication(s) in Google Scholar

Top Publications Citing Use of Products

    PFK-158 purchased from MedChemExpress. Usage Cited in: Cell Rep. 2023 Dec 18;43(1):113557.  [Abstract]

    Cell viability of DIPG IV and SF8628 cells treated with ERK5-IN-1, PFK-158, or combination ERK5-IN-1 and PFK-158 (dual) compared with vehicle control.

    PFK-158 purchased from MedChemExpress. Usage Cited in: Cell Rep. 2023 Dec 18;43(1):113557.  [Abstract]

    Flow cytometry plots with annexin-propidium iodide (PI) assay in SF8268 cells treated with ERK5-IN-1, PFK-158, or combination ERK5-IN-1 and PFK-158 (dual) compared with vehicle control.

    PFK-158 purchased from MedChemExpress. Usage Cited in: Cell Rep. 2023 Dec 18;43(1):113557.  [Abstract]

    Apoptosis of DIPG IV cells treated with ERK5-IN-1, PFK-158, or combination ERK5-IN-1 and PFK-158 (dual) compared with vehicle control.

    PFK-158 purchased from MedChemExpress. Usage Cited in: Cells. 2021 Jul 3;10(7):1679.

    PC9 and H522 cells were transfected with a pEGFP-LC3 plasmid and treated with erlotinib (PC9: 0.5 µM; H522: 2 µM) and/or PFK158 (PC9: 5 µM; H522: 0.75 µM) for 36 h or 24 h respectively, Whole cell lysates were immunoblotted with the indicated antibodies.

    PFK-158 purchased from MedChemExpress. Usage Cited in: Cells. 2021 Jul 3;10(7):1679.

    PC9 and H522 cells were transfected with a pEGFP-LC3 plasmid and treated with erlotinib (PC9: 0.5 µM; H522: 2 µM) and/or PFK158 (PC9: 5 µM; H522: 0.75 µM) for 36 h or 24 h, respectively. GFP-LC3 localization was evaluated by fluorescence microscopy.
    • Biological Activity

    • 순도&문서

    • References

    • 고객리뷰

    제품 설명

    PFK-158 is a potent and selective PFKFB3 inhibitor with an IC50 value 137 nM. PFK-158 reduces glucose uptake, ATP production, lactate release, and induces apoptosis and autophagy in cancer cells. PFK-158 has broad anti-tumor activity. PFK-158 can also enhance Colistin's resistance to bacteria[1][2][3].

    IC50 & Target

    IC50 : 137 nM (PFKFB3)[1][3]

    Cellular Effect
    Cell Line Type Value Description References
    A549 IC50
    15 3
    Compound: A13; PFK-158
    Cytotoxicity against human A549 cells
    Cytotoxicity against human A549 cells
    [PMID: 33766773]
    A549 IC50
    15 3
    Compound: A13; PFK-158
    Cytotoxicity against human A549 cells
    Cytotoxicity against human A549 cells
    [PMID: 33766773]
    In Vitro

    PFK-158 (10 μM ; 24 hours; OV2008 and C13 cells) combined with Carboplatin (CBPt; 77-453 μM) results in significant increase in apoptosis in C13 (45%) and OV2008 cells (24.6%)[1].
    PFK-158 (0-10 μM ; 24 hours; C13 and HeyA8MDR cells) treatment results in a dose-dependent decrease in p-PFKFB3, p-cPLA2 and lipid droplet (LD) levels[1].
    PFK-158 (10 μM; 24 hours) has synergistic anti-proliferative effects in vitro when combined with Cisplatin in C13 and HeyA8MDR cells compared to OV2008 and HeyA8, respectively[1].
    PFK-158 (0‐10 μM; 24 h) treatment shows a dose-dependent downregulation of p62/SQSTM1 and upregulation of LC3BII, two markers of autophagy induction, in both C13 and HeyA8MDR cells. PFK-158 treatment also reduces the numbers of LDs[1].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Apoptosis Analysis[1]

    Cell Line: OV2008 and C13 cells
    Concentration: 10 µM
    Incubation Time: 24 hours
    Result: Combined with Carboplatin (CBPt) treatment resulted in significant increase in apoptosis.

    Western Blot Analysis[1]

    Cell Line: C13 and HeyA8MDR cells
    Concentration: 0 µM, 5 µM, 10 µM
    Incubation Time: 24 hours
    Result: Demonstrated a dose-dependent decrease in p-PFKFB3, p-cPLA2 and lipid droplet (LD) levels.
    In Vivo

    PFK-158 (15 mg/kg; intraperitoneal injection; once a week; for 4 weeks; female athymic nude mice) plus CBPt (51 mg/kg) treatment leads to significantly enhanced antitumor activity in a gynecologic cancer mouse model[1].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Model: Female athymic nude mice (nu/nu) (5-6 weeks old) injected with HeyA8MDR cells[1]
    Dosage: 15 mg/kg
    Administration: Intraperitoneal injection; once a week; for 4 weeks
    Result: A marked reduction of tumor growth was observed in the combination treatment.
    Clinical Trial
    분자량

    328.29

    화학식

    C18H11F3N2O

    CAS No.
    Appearance

    Solid

    Color

    White to light yellow

    SMILES

    O=C(C1=CC=NC=C1)/C=C/C2=NC3=CC(C(F)(F)F)=CC=C3C=C2

    선적

    Room temperature in continental US; may vary elsewhere.

    보관
    Powder -20°C 3 years
    4°C 2 years
    In solvent -80°C 6 months
    -20°C 1 month
    용액&용해도
    In Vitro: 

    DMSO : 50 mg/mL (152.30 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 3.0461 mL 15.2304 mL 30.4609 mL
    5 mM 0.6092 mL 3.0461 mL 6.0922 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    • 몰농도 계산기

    • 농도 희석 계산기

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start)

    C1

    ×
    Volume (start)

    V1

    =
    Concentration (final)

    C2

    ×
    Volume (final)

    V2

    In Vivo:

    For the following dissolution methods, please prepare the working solution directly. It is recommended to prepare fresh solutions and use them promptly within a short period of time.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  50% PEG300    50% Saline

      Solubility: 1.67 mg/mL (5.09 mM); Suspended solution; Need ultrasonic

    • Protocol 2

      Add each solvent one by one:  0.5% CMC-Na/1% Tween-80 in Saline water

      Solubility: 2.48 mg/mL (7.55 mM); Suspended solution; Need ultrasonic

    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Calculation results:
    Working solution concentration: mg/mL
    순도&문서
    References

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    DMSO 1 mM 3.0461 mL 15.2304 mL 30.4609 mL 76.1522 mL
    5 mM 0.6092 mL 3.0461 mL 6.0922 mL 15.2304 mL
    10 mM 0.3046 mL 1.5230 mL 3.0461 mL 7.6152 mL
    15 mM 0.2031 mL 1.0154 mL 2.0307 mL 5.0768 mL
    20 mM 0.1523 mL 0.7615 mL 1.5230 mL 3.8076 mL
    25 mM 0.1218 mL 0.6092 mL 1.2184 mL 3.0461 mL
    30 mM 0.1015 mL 0.5077 mL 1.0154 mL 2.5384 mL
    40 mM 0.0762 mL 0.3808 mL 0.7615 mL 1.9038 mL
    50 mM 0.0609 mL 0.3046 mL 0.6092 mL 1.5230 mL
    60 mM 0.0508 mL 0.2538 mL 0.5077 mL 1.2692 mL
    80 mM 0.0381 mL 0.1904 mL 0.3808 mL 0.9519 mL
    100 mM 0.0305 mL 0.1523 mL 0.3046 mL 0.7615 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    최근 본 상품:

    온라인 문의

    Your information is safe with us. * Required Fields.

    상품명

     

    Requested Quantity *

    고객명 *

     

    호칭

    메일주소 *

     

    전화번호 *

    Department

     

    회사명 *

    City

    Country or Region *

         

    비고

    대량구매 문의

    Inquiry Information

    상품명:
    PFK-158
    Cat. No.:
    HY-12203
    수량:
    MCE Japan Authorized Agent: